Analysis | Metabolite Name | Measured Value | Units | diabetes | time of day |
---|---|---|---|---|---|
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.5119 | VolNormImp Area counts | db/db | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.5894 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.7658 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.8748 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 0.9253 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.0152 | VolNormImp Area counts | db/m | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.0357 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.0668 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.0733 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.1061 | VolNormImp Area counts | db/db | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.1146 | VolNormImp Area counts | db/db | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.1184 | VolNormImp Area counts | db/db | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.3492 | VolNormImp Area counts | db/m | ZT5 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.3796 | VolNormImp Area counts | db/m | ZT17 |
Reversed phase (late) POSITIVE ION MODE | 1,2-dilinoleoyl-GPC (18:2/18:2) | 1.6377 | VolNormImp Area counts | db/m | ZT17 |